Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.


Latest Press Releases

Electronic Caregiver Positions Addison Care as a Transformative Enablement Platform for CMS's New ACCESS Model
Healthcare & PharmaceuticalCompany Update

Electronic Caregiver Positions Addison Care as a Transformative Enablement Platform for CMS's New ACCESS Model

December 2, 2025 7:15 PM

Following CMS's announcement of the new ACCESS Model (Advancing Chronic Care with Effective, Scalable Solutions), Electronic Caregiver, Inc. (ECG) announced its intention to collaborate with eligible Medicare Part B providers and health organizations once CMS releases its list of participating entities in 2026. The ACCESS Model is designed to modernize chronic disease management by incentivizing continuous, tech-enabled care and rewarding...

Read more
Synaptigen Reviews (URGENT REPORT) Does This Sugar-Buildup Fix Really Improve Memory & Cognitive Clarity?
Healthcare & PharmaceuticalAdvertorial

Synaptigen Reviews (URGENT REPORT) Does This Sugar-Buildup Fix Really Improve Memory & Cognitive Clarity?

December 2, 2025 5:15 PM

In 2025 and beyond, cognitive supplements are under more scrutiny than ever, especially formulas claiming to clear "sugar buildup" from neurons, a mechanism increasingly discussed in functional medicine circles. Our investigative review of Synaptigen examines whether this gut-to-brain formula offers more than the usual nootropic promises. With rising reports of digital fatigue, disrupted focus, and early memory decline tied to glucose stress in...

Read more
Neurodivergent Empowerment Institute Announces
Healthcare & PharmaceuticalDiversity, Equity and Inclusion

Neurodivergent Empowerment Institute Announces "Celebrate & Connect" Grand Opening Wellness Event

December 2, 2025 4:25 PM

The Neurodivergent Empowerment Institute (NEI), St. Pete's newest integrative healing center, gallery, and event space, is hosting a full-day grand opening wellness event, "Celebrate & Connect," on Sunday, December 14, 2025, from 12:00 PM to 7:00 PM at 2200 2nd Ave S, Suite 134, St. Petersburg, FL. The event features a powerful lineup of talks that weave together a common theme: Rewriting the future of neurodivergent and trauma-informed care...

Read more
NEI Announces Grand Opening Talk:
Healthcare & PharmaceuticalEnvironmental, Social and Governance

NEI Announces Grand Opening Talk: "The Truth About Autism Treatment"

December 2, 2025 3:55 PM

The Neurodivergent Empowerment Institute (NEI), St. Petersburg's newest integrative health center and neurodivergent-affirming clinic, will host a pivotal presentation titled "The Truth About Autism Treatment" as part of its Grand Opening Wellness Event on Sunday, December 14, 2025, at 2200 2nd Ave S, Suite 134, St. Petersburg, FL. Presented by Angela Fisher, PhD, founder of NEI and creator of the Empowerment-Based Integrated Treatment (EBiT)...

Read more
BreezeMeds GLP-1 Reviews: Complete Guide to Online Weight Loss Program - $199 Semaglutide & Tirzepatide Cost, Safety, Real Results
Healthcare & PharmaceuticalAdvertorial

BreezeMeds GLP-1 Reviews: Complete Guide to Online Weight Loss Program - $199 Semaglutide & Tirzepatide Cost, Safety, Real Results

December 2, 2025 3:50 PM

BreezeMeds Reviews: Complete Guide to This Online GLP-1 Weight Loss Program - Cost, Safety, Results, and What You Need to Know About Telehealth Semaglutide and Tirzepatide Medications TLDR: BreezeMeds is an online telehealth platform offering medically supervised GLP-1 weight loss medications including semaglutide injections starting at $199 per month, oral semaglutide at $299 monthly, and tirzepatide formulations at $399 monthly, with no...

Read more
SynergyRx GLP-1: Telehealth Semaglutide & Tirzepatide Prescriptions With 24/7 Medical Support
Healthcare & PharmaceuticalAdvertorial

SynergyRx GLP-1: Telehealth Semaglutide & Tirzepatide Prescriptions With 24/7 Medical Support

December 2, 2025 3:35 PM

SynergyRx Telehealth Platform Offers Online GLP-1 Weight Management for Eligible Adults with 24/7 Medical Support and Transparent Pricing Nationwide Online Weight Loss Program Provides Access to Semaglutide and Tirzepatide Through Licensed Providers in All 50 States with Comprehensive Patient Support TLDR: SynergyRx is a telemedicine platform offering online GLP-1 prescriptions including semaglutide and tirzepatide for eligible adults seeking...

Read more
Quietum Plus Reviews (SAFETY REPORT) Is This Ear & Tinnitus Supplement Legit or a Risky Bet in 2025?
Healthcare & PharmaceuticalAdvertorial

Quietum Plus Reviews (SAFETY REPORT) Is This Ear & Tinnitus Supplement Legit or a Risky Bet in 2025?

December 2, 2025 3:30 PM

In 2025, tinnitus-related anxiety, sound sensitivity, and early hearing decline are rising faster than most people realize, and the demand for safe, non-invasive solutions has never been higher. That's where Quietum Plus enters the conversation: a natural hearing support supplement positioned as a way to nourish auditory nerves, balance stress pathways, and reinforce the brain-ear connection without prescription drugs or invasive devices. But...

Read more
President Trump's Most Difficult Marijuana Decision: Why MMJ International Holding Is A Solution
Healthcare & PharmaceuticalCompany Update

President Trump's Most Difficult Marijuana Decision: Why MMJ International Holding Is A Solution

December 2, 2025 3:25 PM

President Donald Trump now faces one of the most complex drug-policy decisions in modern American history: whether to reschedule marijuana under the Controlled Substances Act (CSA). While industry lobbyists portray rescheduling as a simple political win, the reality is far more explosive - legally, geopolitically, and medically. Behind closed doors, senior officials acknowledge that a broad rescheduling move is not merely a regulatory step, but...

Read more
Exousia Pro, Inc. Completes Exclusive Licensing Agreement With the University of Central Florida for Novel Cancer Diagnostic and Therapy Platforms
Healthcare & PharmaceuticalCompany Update

Exousia Pro, Inc. Completes Exclusive Licensing Agreement With the University of Central Florida for Novel Cancer Diagnostic and Therapy Platforms

December 2, 2025 1:45 PM

Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based delivery systems, today announced the execution of an exclusive licensing agreement between its wholly owned subsidiary, Exousia Pro Holding Management, LLC, and the University of Central Florida (UCF) concerning its groundbreaking technology for both the diagnosis and treatment of cancer using exosomes. Securing Foundational, Worldwide...

Read more
Top Workplace Converted to Santa's Workshop on Giving Tuesday to Spread 'Big Love' This Holiday Season
Healthcare & PharmaceuticalPartnerships

Top Workplace Converted to Santa's Workshop on Giving Tuesday to Spread 'Big Love' This Holiday Season

December 2, 2025 1:00 PM

US Med-Equip's workshop ordinarily contains life-saving equipment for hospitals, but this Giving Tuesday Santa's elves at the "Top Workplace" also spread holiday cheer to children and families supported by B.I.G. Love Cancer Care. US Med-Equip (USME) elves are collecting toys, blankets, art supplies, cozy pajamas and more for kids spending their holidays in the hospital. "Every day, our teams move mountains to help hospitals care for patients...

Read more
Catalyzing Change in Specialty Care: DaVita Shares Vision for Technology Transformation
Healthcare & PharmaceuticalEnvironmental, Social and Governance

Catalyzing Change in Specialty Care: DaVita Shares Vision for Technology Transformation

December 2, 2025 10:35 AM

Approximately 129 million Americans are living with at least one chronic condition, and fragmentation of care creates a significant hurdle as these individuals often find themselves navigating a complex web of health care services. "When you have a chronic condition, you end up engaging with your specialist significantly more - over three times as often - than you do with your primary care physician," Joel Haugen, chief product officer for...

Read more
Trial Library Raises $10 Million Series A to Expand Access to Clinical Trials as a Care Option
Healthcare & PharmaceuticalCompany Update

Trial Library Raises $10 Million Series A to Expand Access to Clinical Trials as a Care Option

December 2, 2025 10:00 AM

Trial Library, an AI-enabled platform expanding access to clinical trials as a care option, announced a $10 million Series A funding round co-led by SemperVirens Venture Capital and Next Ventures, with participation from Sanofi Ventures, Lux Capital, Civilization Ventures, How Women Invest, Overwater Ventures and others. This investment, which brings total funding to date of $15 million, accelerates Trial Library's mission to make clinical...

Read more
John H. Weston Jr. Featured in New Industry Spotlight Highlighting Leadership in Developmental Disability Support
Healthcare & PharmaceuticalCompany Update

John H. Weston Jr. Featured in New Industry Spotlight Highlighting Leadership in Developmental Disability Support

December 2, 2025 10:00 AM

Capitol City Residential Health Care CEO John H. Weston Jr. is the focus of a newly released feature article exploring his career, leadership philosophy, and long-standing commitment to supporting individuals with intellectual and developmental disabilities. Drawing from the interview, Weston is using the opportunity to call for greater public awareness, stronger community partnerships, and increased support for individuals who face both...

Read more
Tobinworld Calls for Greater Support for Children with Dual Diagnoses
Healthcare & PharmaceuticalCompany Update

Tobinworld Calls for Greater Support for Children with Dual Diagnoses

December 2, 2025 9:55 AM

Tobinworld Mental Health, a long-standing non-profit dedicated to helping children and teens with developmental disabilities and mental health conditions, is calling for increased awareness and community involvement to support children with dual diagnoses. These are young people who live with both a developmental condition, such as autism, and a mental health disorder like anxiety, depression, or behavioral dysregulation. "Many families struggle...

Read more
Medical Care Technologies Inc. (OTC PINK:MDCE) Expands Development of Consumer-Grade AI Pre-Health Screening Tools Focused on Early Detection
Healthcare & PharmaceuticalCompany Update

Medical Care Technologies Inc. (OTC PINK:MDCE) Expands Development of Consumer-Grade AI Pre-Health Screening Tools Focused on Early Detection

December 2, 2025 9:30 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) announced today that the company is expanding its development efforts into a new generation of consumer-grade AI pre-health screening mobile applications designed to help identify early warning signs of serious health conditions and encourage timely medical intervention. This initiative builds upon MDCE's previously announced breakthrough in early melanoma detection. The company is now leveraging...

Read more
StimCell Energetics Inc. Announces Study into eBalance(R) Device's Impact on Neuronal Mitochondrial Function
Healthcare & PharmaceuticalCompany Update

StimCell Energetics Inc. Announces Study into eBalance(R) Device's Impact on Neuronal Mitochondrial Function

December 2, 2025 9:15 AM

StimCell Energetics Inc. (OTCQB:STME) ("StimCell" or the "Company"), a biotech pioneer targeting cellular energy to enhance wellness, anti-aging, and longevity, today announced the signing of a service agreement with the St. Boniface Hospital Albrechtsen Research Centre, affiliated with the University of Manitoba, and Principal Investigator, Professor Paul Fernyhough. This collaboration will explore the effects of StimCell's proprietary...

Read more
Lumina360 Platform to Streamline Complex Care for Skilled Nursing
Healthcare & PharmaceuticalProduct Announcements

Lumina360 Platform to Streamline Complex Care for Skilled Nursing

December 2, 2025 9:00 AM

Lumina Care announced the launch of a new care delivery analysis platform, called Lumina360, that helps improve care continuity and quality throughout the patient journey. Lumina360 provides real-time vitals, statistics, information, and analysis that integrates with electronic health records (EHR) to create a clear picture of an individual patient's health and provides facility-level oversight, improving treatment outcomes and compliance. The...

Read more
Aspire Biopharma Submits Pre-IND Meeting Request and Briefing Package to U.S. FDA for Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack)
Healthcare & PharmaceuticalCompany Update

Aspire Biopharma Submits Pre-IND Meeting Request and Briefing Package to U.S. FDA for Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack)

December 2, 2025 9:00 AM

Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug delivery technology, is pleased to announce that on November 3, 2025, it submitted its Pre-IND meeting request and briefing package to the U.S. Food and Drug Administration (FDA). The submission concerns the Company's lead product candidate, a fast-acting, high-dose sublingual aspirin formulation for the treatment of...

Read more
Who Does the Best Tummy Tuck in Sarasota?
Healthcare & PharmaceuticalAdvertorial

Who Does the Best Tummy Tuck in Sarasota?

December 2, 2025 9:00 AM

For patients in Southwest Florida comparing tummy tuck options, one name comes up repeatedly in search results, professional directories, and third-party press coverage: Dr. Alberico J. Sessa, founder of Sarasota Surgical Arts and a cosmetic surgeon whose practice has become closely associated with abdominoplasty in the Sarasota area. A Sarasota Surgeon Whose Practice Centers on Tummy Tuck On the dedicated tummy tuck in Sarasota page of Sarasota...

Read more
Jaguar Health Makes Submission to EMA Regarding EU Approval Pathway for Canalevia for General Diarrhea in Dogs Based on Data from Completed Study
Healthcare & PharmaceuticalCompany Update

Jaguar Health Makes Submission to EMA Regarding EU Approval Pathway for Canalevia for General Diarrhea in Dogs Based on Data from Completed Study

December 2, 2025 9:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar), today announced that its Italian subsidiary, Napo Therapeutics S.p.A., has submitted a request to the European Medicines Agency (EMA) to have the EMA's Committee for Veterinary Medicinal Products (CVMP) provide scientific advice regarding the company's plan to pursue approval of Canalevia (crofelemer delayed-release tablets) in the European Union for treatment of general diarrhea in dogs based on data...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers • July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie • July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers • July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers • June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers • June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers • June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?